These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 28556946)

  • 1. Dexmedetomidine protects mice against myocardium ischaemic/reperfusion injury by activating an AMPK/PI3K/Akt/eNOS pathway.
    Sun Y; Jiang C; Jiang J; Qiu L
    Clin Exp Pharmacol Physiol; 2017 Sep; 44(9):946-953. PubMed ID: 28556946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of dexmedetomidine postconditioning on myocardial ischemia and the role of the PI3K/Akt-dependent signaling pathway in reperfusion injury.
    Cheng XY; Gu XY; Gao Q; Zong QF; Li XH; Zhang Y
    Mol Med Rep; 2016 Jul; 14(1):797-803. PubMed ID: 27221008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of dexmedetomidine on myocardial ischemia-reperfusion injury through PI3K-Akt-mTOR signaling pathway.
    Zhang J; Jiang H; Liu DH; Wang GN
    Eur Rev Med Pharmacol Sci; 2019 Aug; 23(15):6736-6743. PubMed ID: 31378917
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Over-expression of HSPA12B protects mice against myocardium ischemic/reperfusion injury through a PPARγ-dependent PI3K/Akt/eNOS pathway.
    Sun Y; Ye L; Jiang C; Jiang J; Hong H; Qiu L
    Am J Transl Res; 2015; 7(12):2724-37. PubMed ID: 26885270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The protective effect of dexmedetomidine on LPS-induced acute lung injury through the HMGB1-mediated TLR4/NF-κB and PI3K/Akt/mTOR pathways.
    Meng L; Li L; Lu S; Li K; Su Z; Wang Y; Fan X; Li X; Zhao G
    Mol Immunol; 2018 Feb; 94():7-17. PubMed ID: 29241031
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dexmedetomidine protects the heart against ischemia-reperfusion injury by an endothelial eNOS/NO dependent mechanism.
    Riquelme JA; Westermeier F; Hall AR; Vicencio JM; Pedrozo Z; Ibacache M; Fuenzalida B; Sobrevia L; Davidson SM; Yellon DM; Sánchez G; Lavandero S
    Pharmacol Res; 2016 Jan; 103():318-27. PubMed ID: 26607864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of Dexmedetomidine Postconditioning on Myocardial Ischemia/Reperfusion Injury in Diabetic Rats: Role of the PI3K/Akt-Dependent Signaling Pathway.
    Cheng X; Hu J; Wang Y; Ye H; Li X; Gao Q; Li Z
    J Diabetes Res; 2018; 2018():3071959. PubMed ID: 30402501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adiponectin protects against myocardial ischaemia-reperfusion injury via AMP-activated protein kinase, Akt, and nitric oxide.
    Gonon AT; Widegren U; Bulhak A; Salehzadeh F; Persson J; Sjöquist PO; Pernow J
    Cardiovasc Res; 2008 Apr; 78(1):116-22. PubMed ID: 18222959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dexmedetomidine pretreatment protects the heart against apoptosis in ischemia/reperfusion injury in diabetic rats by activating PI3K/Akt signaling in vivo and in vitro.
    Chang JH; Jin MM; Liu JT
    Biomed Pharmacother; 2020 Jul; 127():110188. PubMed ID: 32407987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of carvacrol in cardioprotection against myocardial ischemia/reperfusion injury in rats through activation of MAPK/ERK and Akt/eNOS signaling pathways.
    Chen Y; Ba L; Huang W; Liu Y; Pan H; Mingyao E; Shi P; Wang Y; Li S; Qi H; Sun H; Cao Y
    Eur J Pharmacol; 2017 Feb; 796():90-100. PubMed ID: 27916558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dexmedetomidine alleviates lung ischemia-reperfusion injury in rats by activating PI3K/Akt pathway.
    Liang S; Wang Y; Liu Y
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):370-377. PubMed ID: 30657579
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective effect of ligustrazine against myocardial ischaemia reperfusion in rats: the role of endothelial nitric oxide synthase.
    Lv L; Jiang SS; Xu J; Gong JB; Cheng Y
    Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):20-7. PubMed ID: 22004361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardioprotection of hydralazine against myocardial ischemia/reperfusion injury in rats.
    Li C; Su Z; Ge L; Chen Y; Chen X; Li Y
    Eur J Pharmacol; 2020 Feb; 869():172850. PubMed ID: 31830459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexmedetomidine attenuates renal ischemia-reperfusion injury through activating PI3K/Akt-eNOS signaling via α
    Shan X; Zhang J; Wei X; Tao W; Peng K; Liu H; Wang Y; Liu H; Meng X; Ji F
    FASEB J; 2022 Nov; 36(11):e22608. PubMed ID: 36250975
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Salidroside improves endothelial function and alleviates atherosclerosis by activating a mitochondria-related AMPK/PI3K/Akt/eNOS pathway.
    Xing SS; Yang XY; Zheng T; Li WJ; Wu D; Chi JY; Bian F; Bai XL; Wu GJ; Zhang YZ; Zhang CT; Zhang YH; Li YS; Jin S
    Vascul Pharmacol; 2015 Sep; 72():141-52. PubMed ID: 26187353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ischaemic preconditioning-induced serum exosomes protect against myocardial ischaemia/reperfusion injury in rats by activating the PI3K/AKT signalling pathway.
    Zhang J; Zhang X
    Cell Biochem Funct; 2021 Mar; 39(2):287-295. PubMed ID: 32767595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heart protective effects and mechanism of quercetin preconditioning on anti-myocardial ischemia reperfusion (IR) injuries in rats.
    Liu H; Guo X; Chu Y; Lu S
    Gene; 2014 Jul; 545(1):149-55. PubMed ID: 24769323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hydromorphine postconditioning protects isolated rat heart against ischemia-reperfusion injury via activating P13K/Akt/eNOS signaling.
    Liu Q; Li Z; Liu Y; Xiao Q; Peng X; Chen Q; Deng R; Gao Z; Yu F; Zhang Y
    Cardiovasc Ther; 2018 Dec; 36(6):e12481. PubMed ID: 30597772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hydrogen‑rich solution against myocardial injury and aquaporin expression via the PI3K/Akt signaling pathway during cardiopulmonary bypass in rats.
    Song D; Liu X; Diao Y; Sun Y; Gao G; Zhang T; Chen K; Pei L
    Mol Med Rep; 2018 Aug; 18(2):1925-1938. PubMed ID: 29956781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dexmedetomidine alleviates hepatic ischaemia-reperfusion injury via the PI3K/AKT/Nrf2-NLRP3 pathway.
    Wu Y; Qiu G; Zhang H; Zhu L; Cheng G; Wang Y; Li Y; Wu W
    J Cell Mol Med; 2021 Nov; 25(21):9983-9994. PubMed ID: 34664412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.